Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 6/2010

01-06-2010 | Original paper

Estimation of cancer incidence and mortality attributable to smoking in China

Authors: Jian-Bing Wang, Yong Jiang, Wen-Qiang Wei, Gong-Huan Yang, You-Lin Qiao, Paolo Boffetta

Published in: Cancer Causes & Control | Issue 6/2010

Login to get access

Abstract

Background

Tobacco smoking, as a cause of cancer, is common in China. Few studies have been conducted to assess the burden of tobacco-related cancer in the Chinese population.

Methods

We calculated the proportion of cancers attributable to tobacco smoking to estimate the burden of tobacco-related cancer. Population attributable fraction was calculated based on the assumption of total avoidance of smoking. Data on smoking prevalence were from two large-scale national surveys of representative samples of the Chinese population. Data on relative risk were derived from the meta-analyses and large-scale studies. Cancer mortality and incidence were originated from the third national death cause survey and cancer registries in China.

Results

We estimated that a total of 405,112 deaths of cancer were attributable to smoking in China in 2005, including 372,264 among men (32.7% of all cancer deaths) and 32,848 among women (5.0%). A total of 495,221 cancer cases were attributable to smoking, including 454,785 among men (30.0% of all cancer cases) and 40,436 among women (3.9%). Involuntary smoking was responsible for 11,507 lung cancer deaths (11.1%) among non-smoking women.

Conclusion

Tobacco smoking is responsible for one-third of the total cancer deaths among men. Involuntary smoking is an important individual risk factor for lung cancer among non-smoking women. There is a need to continue and strengthen tobacco-control programs and initiatives to reduce smoking-related cancer burden in China.
Literature
1.
2.
International Agency for Research on Cancer (2004) IARC Monographs on the evaluation of the carcinogenic risk to humans, Vol. 83, Tobacco Smoke and Involuntary Smoking. IARC Press, Lyon
3.
Ministry of Health of the people’s republic of China (2008) Report on the Third national Retrospective Survey of Death causes in China. Chinese Academy of Medical Sciences & Peking Union Medical College Press, Beijing
4.
World Health Organization (2002) The World Health Report 2002: Reducing Risks, Promoting Healthy Life. WHO, Geneva
5.
Yang GH, Ma JM, Liu N, Zhou LN (2005) Smoking and passive smoking in Chinese, 2002. Zhonghua Liu Xing Bing Xue Za Zhi 26:77–83PubMed
6.
Yang GH, Fan LX, Tan J et al (1999) Smoking in China: findings of the 1996 national prevalence survey. JAMA 282:1247–1253CrossRefPubMed
7.
Lopez AD, Collishaw NE, Piha T (1994) A descriptive model of the cigarette epidemic in developed countries. Tob control 3:242–247CrossRef
8.
Peto R (1994) Smoking and death: the past 40 years and the next 40. BMJ 309:937–939PubMed
9.
Peto R, Lopez AD (1990) The future worldwide health effects of current smoking patterns: 3 million deaths per year in the 1990’s, but over 10 million annually. In: Program and abstracts of the 7th World Conference on Tobacco and Health. Perth, Australia
10.
Niu SR, Yang GH, Chen ZM et al (1998) Emerging tobacco hazards in China: 2. Early mortality results from a prospective study. BMJ 317:1423–1424PubMed
11.
Gu DF, Kelly TN, Wu XG et al (2009) Mortality attributable to smoking in China. N Engl J Med 360:150–159CrossRefPubMed
12.
Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 309:901–911PubMed
13.
Weng XZ, Hong ZG, Chen DY (1987) Smoking prevalence in Chinese aged 15 and above. Chin Med J (Engl) 100:886–892
14.
Liu BQ, Peto R, Chen ZM et al (1998) Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 317:1411–1422PubMed
15.
Han MY, Yin GJ, Chen WQ (2005) Meta-analysis of risk factors associated with nasopharyngeal carcinoma in China. China Tropical Medicine 5:1442–1443
16.
Tran GD, Sun XD, Abnet CC (2005) Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 20(113):456–463CrossRef
17.
Liu YX, Wang JZ (2002) Meta-analysis of the relationship between smoking and stomach cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24:559–563PubMed
18.
Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R (2003) Smoking and liver cancer in China: case-control comparison of 36, 000 liver cancer deaths vs. 17, 000 cirrhosis deaths. Int J Cancer 107:106–112CrossRefPubMed
19.
Shi J, Ch WU, Liu S, Xie WF (2004) Meta analysis of risk factors for pancreatic cancer in China. Chin J Pancreatol 4:154–158
20.
Dai Q, Mu BT, Xu M, Gao YT (1994) Analysis of attributable fraction for smoking and some main cancers in shanghai. Tumor 14:209–210
21.
Gandini S, Botteri E, Iodice S et al (2008) Tobacco smoking and cancer: a meta-analysis. Int J Cancer 122:155–164CrossRefPubMed
22.
Gao YT, Den J, Xiang YB et al (1999) Smoking, related cancers, and other diseases in Shanghai: a 10-year prospective study. Zhonghua Yu Fang Yi Xue Za Zhi 33:5–8PubMed
23.
Wen WQ, Shu XO, Gao YT et al (2006) Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study. BMJ 333:376CrossRefPubMed
24.
Chen WQ (2009) Estimation of cancer incidence and mortality in China in 2004–2005. Chin J Oncol 31:664–668
25.
Levin ML (1953) The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 9:531–541PubMed
26.
Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5, version 2.0. IARC Press, Lyon
27.
Yuan JM, Ross RK, Wang XL, Gao YT, Henderson BE, Yu MC (1996) Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA 275:1646–1650CrossRefPubMed
28.
Peto R, Lopez AD, Boreham J, Thun M (1994) Mortality from smoking in developed countries 1950–2000. Oxford University Press, Oxford
29.
International Agency for Research on Cancer, Académie des Sciences–Institut de France, Académie de Médecine, Fédération Nationale des Centres de Lutte contre le Cancer (2007) IARC working group reports, Vol 3, attributable causes of cancer in France in the year 2000. IARC Press, Lyon
30.
Wells AJ (1988) An estimate of adult mortality in the United States from passive smoking. Environ Int 14:249–265CrossRef
31.
Wells AJ (1992) An estimate of adult mortality in the United States from passive smoking; a further reply (letter). Environ Int 18:321–325
32.
Doll R, Gray R, Hafner B, Peto R (1980) Mortality in relation to smoking: 22 years’ observations on female British doctors. Br Med J 280:967–971CrossRefPubMed
33.
Boffetta P, Kreuzer M, Benhamou S et al (2001) Risk of lung cancer from tobacco smoking among young women from Europe. Int J Cancer 91:745–746CrossRefPubMed
Metadata
Title
Estimation of cancer incidence and mortality attributable to smoking in China
Authors
Jian-Bing Wang
Yong Jiang
Wen-Qiang Wei
Gong-Huan Yang
You-Lin Qiao
Paolo Boffetta
Publication date
01-06-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 6/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9523-8

Other articles of this Issue 6/2010

Cancer Causes & Control 6/2010 Go to the issue

Original paper

Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies

Original paper

Diabetes and risk of incident cancer: a large population-based cohort study in Israel

Original paper

Alcohol and risk of breast cancer in Mexican women

Original paper

Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study

Original paper

A bupropion smoking cessation clinical trial for cancer patients

Original paper

Non-cancer mortality among long-term survivors of adult cancer in Korea: national cancer registry study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits